Edition:
United States

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

525.55INR
6:25am EDT
Change (% chg)

Rs-0.65 (-0.12%)
Prev Close
Rs526.20
Open
Rs526.00
Day's High
Rs531.50
Day's Low
Rs515.80
Volume
5,009,819
Avg. Vol
2,188,581
52-wk High
Rs895.00
52-wk Low
Rs515.80

ARBN.NS

Chart for ARBN.NS

About

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system,... (more)

Overall

Beta: 0.96
Market Cap(Mil.): Rs308,291.31
Shares Outstanding(Mil.): 585.88
Dividend: 1.25
Yield (%): 0.62

Financials

  ARBN.NS Industry Sector
P/E (TTM): 13.18 14.35 17.42
EPS (TTM): 39.91 -- --
ROI: -- -7.29 -5.45
ROE: -- -6.80 -4.73

BRIEF-Aurobindo Pharma says US FDA issued form 483 with 6 observations for unit-III

* Clarifies on news item "US FDA issues 5-6 'largely procedural' observations to Aurobindo Pharma's Unit-III"

Apr 19 2017

BRIEF-Aurobindo Pharma gets FDA nod for generic drug to treat HIV-1 infection

* Says Aurobindo Pharma receives USFDA approval for generic Epzicom tablets

Mar 30 2017

BRIEF-Aurobindo Pharma gets USFDA nod for Meropenem injection

* Meropenem injection is a generic equivalent of Astrazeneca Pharma's Merrem injection

Mar 28 2017

BRIEF-Aurobindo Pharma gets FDA nod for generic version of Reckitt Benckiser’s Mucinex DM tablets

* Says Aurobindo Pharma receives USFDA approval for guaifenesin and dextromethorphan hydrobromide

Mar 20 2017

Aurobindo plans second U.S. plant as Trump calls for local production

MUMBAI Indian drugmaker Aurobindo Pharma plans to set up a factory in the United States for injectable products, it said on Friday, days after U.S. President Donald Trump called on pharmaceutical companies to make more drugs locally.

Feb 10 2017

UPDATE 1-Aurobindo plans second U.S. plant as Trump calls for local production

MUMBAI, Feb 10 Indian drugmaker Aurobindo Pharma plans to set up a factory in the United States for injectable products, it said on Friday, days after U.S. President Donald Trump called on pharmaceutical companies to make more drugs locally.

Feb 10 2017

India's Aurobindo eyes U.S. plant amid Trump push on jobs

MUMBAI, Feb 10 Indian drugmaker Aurobindo Pharma said on Friday it was looking to set up a manufacturing facility for injectable products in the United States, days after President Donald Trump called on pharmaceutical companies to make more drugs locally.

Feb 10 2017

India's Aurobindo shares hit nine-month low on US price-fixing lawsuit

MUMBAI Indian drugmaker Aurobindo Pharma Ltd's shares hit their lowest in more than nine months on Friday after the company was named in a lawsuit alleging it colluded with other drugmakers to fix prices of two commonly used drugs in the United States.

Dec 16 2016

More From Around the Web

Earnings vs. Estimates